Reply: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?
- PMID: 23634866
- PMCID: PMC12057419
- DOI: 10.1164/rccm.201211-2060LE
Reply: A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?
Comment on
-
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2012 Jul 1;186(1):88-95. doi: 10.1164/rccm.201202-0314OC. Epub 2012 May 3. Am J Respir Crit Care Med. 2012. PMID: 22561965 Free PMC article. Clinical Trial.
-
Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis?Am J Respir Crit Care Med. 2012 Oct 1;186(7):693; author reply 693-4. doi: 10.1164/ajrccm.186.7.693. Am J Respir Crit Care Med. 2012. PMID: 23027854 Free PMC article. No abstract available.
-
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis: a hidden subgroup?Am J Respir Crit Care Med. 2013 May 1;187(9):1029-30. doi: 10.1164/rccm.201210-1782LE. Am J Respir Crit Care Med. 2013. PMID: 23634865 No abstract available.
References
-
- Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest . 2005;128:1475–1482. - PubMed
-
- Nakashima T, Yokoyama A, Inata J, Ishikawa N, Haruta Y, Hattori N, Kohno N. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS. Chest . 2011;139:296–304. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
